Unlike IDO1 and IDO2, which are widely expressed on various types of cells, including tumor cells, TAMs and DCs, TDO2 was found to be selectively expressed on liver cancer cells and brain tumor cells (56), and it was also found to have greater Kyn production ability in comparison with IDO1/-2 (38). The gene discussed is TDO2; the disease is liver cancer.